MIR133A2 (microRNA 133a-2) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: MIR133A2 (microRNA 133a-2) Homo sapiens
Analyze
Symbol: MIR133A2
Name: microRNA 133a-2
RGD ID: 1343982
HGNC Page HGNC:31518
Description: Enables mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including negative regulation of low-density lipoprotein particle clearance; negative regulation of vascular associated smooth muscle cell proliferation; and regulation of gene expression. Located in extracellular space.
Type: ncrna (Ensembl: miRNA)
RefSeq Status: PROVISIONAL
Previously known as: mir-133a-2; MIRN133A2
RGD Orthologs
Mouse
Rat
Dog
Pig
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382062,564,912 - 62,565,013 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2062,564,912 - 62,565,013 (+)EnsemblGRCh38hg38GRCh38
GRCh372061,162,119 - 61,162,220 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 362060,572,563 - 60,572,664 (+)NCBINCBI36Build 36hg18NCBI36
Celera2057,872,455 - 57,872,556 (+)NCBICelera
Cytogenetic Map20q13.33NCBI
HuRef2057,916,762 - 57,916,863 (+)NCBIHuRef
CHM1_12061,063,178 - 61,063,279 (+)NCBICHM1_1
T2T-CHM13v2.02064,363,437 - 64,363,538 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
hexanal  (ISO)
warfarin  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
cellular response to cytokine stimulus  (IDA)
cellular response to leukemia inhibitory factor  (ISO)
miRNA-mediated gene silencing by mRNA destabilization  (IDA)
miRNA-mediated post-transcriptional gene silencing  (IDA,IEA,IMP,ISO)
negative regulation of cardiac muscle cell apoptotic process  (ISS)
negative regulation of cardiac muscle hypertrophy  (ISS)
negative regulation of cell migration  (IDA)
negative regulation of cell population proliferation  (IDA)
negative regulation of epidermal growth factor receptor signaling pathway  (IDA)
negative regulation of ERK1 and ERK2 cascade  (ISS)
negative regulation of G1/S transition of mitotic cell cycle  (ISS)
negative regulation of gene expression  (ISO)
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide  (ISS)
negative regulation of low-density lipoprotein particle clearance  (IDA)
negative regulation of membrane repolarization during cardiac muscle cell action potential  (IMP)
negative regulation of myoblast proliferation  (ISS)
negative regulation of osteoblast differentiation  (ISO)
negative regulation of vascular associated smooth muscle cell proliferation  (IDA)
negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane  (IDA)
positive regulation of cardiocyte differentiation  (IDA)
positive regulation of cell fate commitment  (ISS)
positive regulation of gene expression  (IDA)
positive regulation of myotube differentiation  (ISS)
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway  (ISS)
regulation of cardiac muscle cell proliferation  (ISO)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion  (ISS)
regulation of heart rate by hormone  (ISS)
regulation of membrane repolarization during ventricular cardiac muscle cell action potential  (ISS)
regulation of ventricular cardiac muscle cell membrane repolarization  (ISS)
response to bacterium  (ISO)
response to oxygen levels  (ISO)

Cellular Component

Molecular Function

References
Additional References at PubMed
PMID:12007417   PMID:16381832   PMID:16731620   PMID:17604727   PMID:20075508   PMID:20159880   PMID:20468068   PMID:20889907   PMID:21037258   PMID:21109942   PMID:22089643   PMID:22163007  
PMID:22766685   PMID:23034410   PMID:23069713   PMID:23157812   PMID:23535732   PMID:24816813   PMID:24920580   PMID:24975488   PMID:25146754   PMID:25170220   PMID:25607810   PMID:25780292  
PMID:26005035   PMID:26276722   PMID:26646931   PMID:26984682   PMID:27154818   PMID:28257760   PMID:28869447   PMID:29771401   PMID:29957467   PMID:30289952   PMID:30300116   PMID:30458455  
PMID:30810894   PMID:31005252   PMID:31249372   PMID:31254364   PMID:31350524   PMID:31381269   PMID:31511493   PMID:32061123   PMID:32205184   PMID:32218383   PMID:32462982   PMID:32724467  
PMID:32928707   PMID:33222435   PMID:33501869   PMID:34057242   PMID:36042288   PMID:36305754   PMID:36656380  


Genomics

Comparative Map Data
MIR133A2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382062,564,912 - 62,565,013 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2062,564,912 - 62,565,013 (+)EnsemblGRCh38hg38GRCh38
GRCh372061,162,119 - 61,162,220 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 362060,572,563 - 60,572,664 (+)NCBINCBI36Build 36hg18NCBI36
Celera2057,872,455 - 57,872,556 (+)NCBICelera
Cytogenetic Map20q13.33NCBI
HuRef2057,916,762 - 57,916,863 (+)NCBIHuRef
CHM1_12061,063,178 - 61,063,279 (+)NCBICHM1_1
T2T-CHM13v2.02064,363,437 - 64,363,538 (+)NCBIT2T-CHM13v2.0
Mir133a-2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm392180,040,172 - 180,040,275 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl2180,040,172 - 180,040,275 (+)EnsemblGRCm39 Ensembl
GRCm382180,398,379 - 180,398,482 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl2180,398,379 - 180,398,482 (+)EnsemblGRCm38mm10GRCm38
MGSCv372180,133,084 - 180,133,187 (+)NCBIGRCm37MGSCv37mm9NCBIm37
Celera2184,483,296 - 184,483,399 (+)NCBICelera
Cytogenetic Map2H4NCBI
cM Map2102.93NCBI
Mir3582
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8182,157,853 - 2,157,970 (+)NCBIGRCr8
mRatBN7.2181,885,063 - 1,885,180 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl181,885,063 - 1,885,180 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx182,114,703 - 2,114,820 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0182,902,404 - 2,902,521 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0182,116,585 - 2,116,702 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0182,052,459 - 2,052,576 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl182,052,459 - 2,052,576 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0182,085,438 - 2,085,555 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera181,764,854 - 1,764,971 (+)NCBICelera
Cytogenetic Map18p13NCBI
MIR133C
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.12446,490,501 - 46,490,586 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2446,490,497 - 46,490,588 (+)EnsemblCanFam3.1canFam3CanFam3.1
ROS_Cfam_1.02447,360,810 - 47,360,895 (+)NCBIROS_Cfam_1.0
UMICH_Zoey_3.12446,462,042 - 46,462,127 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02446,585,253 - 46,585,338 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.02447,339,810 - 47,339,895 (+)NCBIUU_Cfam_GSD_1.0
MIR133A-1
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1761,904,781 - 61,904,883 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11761,904,781 - 61,904,883 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21769,274,653 - 69,274,755 (-)NCBISscrofa10.2Sscrofa10.2susScr3


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 20q13.33(chr20:62455231-63839491)x1 copy number loss See cases [RCV000052768] Chr20:62455231..63839491 [GRCh38]
Chr20:61030287..62470844 [GRCh37]
Chr20:60463682..61941288 [NCBI36]
Chr20:20q13.33		 pathogenic
GRCh38/hg38 20q13.33(chr20:62545370-64241486)x1 copy number loss See cases [RCV000052769] Chr20:62545370..64241486 [GRCh38]
Chr20:61142577..62872839 [GRCh37]
Chr20:60553022..62343283 [NCBI36]
Chr20:20q13.33		 pathogenic
GRCh38/hg38 20q13.33(chr20:62561794-63331723)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052770]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052770]|See cases [RCV000052770] Chr20:62561794..63331723 [GRCh38]
Chr20:61211869..61963075 [GRCh37]
Chr20:60569446..61433519 [NCBI36]
Chr20:20q13.33		 pathogenic
GRCh38/hg38 20q13.12-13.33(chr20:44787704-64277321)x3 copy number gain See cases [RCV000053035] Chr20:44787704..64277321 [GRCh38]
Chr20:43416345..62908674 [GRCh37]
Chr20:42849759..62379118 [NCBI36]
Chr20:20q13.12-13.33		 pathogenic
NC_000020.10:g.(?_60831241)_(62664346_?)dup duplication Developmental and epileptic encephalopathy, 33 [RCV001295457]|Early infantile epileptic encephalopathy with suppression bursts [RCV001316934] Chr20:60831241..62664346 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh38/hg38 20q13.33(chr20:62561794-64277321)x1 copy number loss See cases [RCV000133842] Chr20:62561794..64277321 [GRCh38]
Chr20:61211869..62908674 [GRCh37]
Chr20:60569446..62379118 [NCBI36]
Chr20:20q13.33		 pathogenic
GRCh38/hg38 20q13.32-13.33(chr20:59041966-64277321)x3 copy number gain See cases [RCV000135805] Chr20:59041966..64277321 [GRCh38]
Chr20:57617021..62908674 [GRCh37]
Chr20:57050416..62379118 [NCBI36]
Chr20:20q13.32-13.33		 pathogenic
GRCh38/hg38 20p13-q13.33(chr20:99557-64277321)x3 copy number gain See cases [RCV000135859] Chr20:99557..64277321 [GRCh38]
Chr20:80198..62908674 [GRCh37]
Chr20:28198..62379118 [NCBI36]
Chr20:20p13-q13.33		 pathogenic
GRCh38/hg38 20q13.2-13.33(chr20:56198032-64277321)x3 copy number gain See cases [RCV000138035] Chr20:56198032..64277321 [GRCh38]
Chr20:54773088..62908674 [GRCh37]
Chr20:54206495..62379118 [NCBI36]
Chr20:20q13.2-13.33		 pathogenic
GRCh38/hg38 20q13.33(chr20:61326549-64277326)x3 copy number gain See cases [RCV000139100] Chr20:61326549..64277326 [GRCh38]
Chr20:59901605..62908679 [GRCh37]
Chr20:59335000..62379123 [NCBI36]
Chr20:20q13.33		 pathogenic
GRCh38/hg38 20q13.31-13.33(chr20:57229415-64273089)x3 copy number gain See cases [RCV000141347] Chr20:57229415..64273089 [GRCh38]
Chr20:55804471..62904442 [GRCh37]
Chr20:55237878..62374886 [NCBI36]
Chr20:20q13.31-13.33		 pathogenic
GRCh38/hg38 20q13.2-13.33(chr20:53236165-64284202)x3 copy number gain See cases [RCV000143584] Chr20:53236165..64284202 [GRCh38]
Chr20:51852704..62915555 [GRCh37]
Chr20:51286111..62385999 [NCBI36]
Chr20:20q13.2-13.33		 likely pathogenic
GRCh37/hg19 20q13.33(chr20:60882468-62045494)x1 copy number loss Breast ductal adenocarcinoma [RCV000207130] Chr20:60882468..62045494 [GRCh37]
Chr20:20q13.33		 uncertain significance
chr20:60885242-61929348 complex variant complex Breast ductal adenocarcinoma [RCV000207152] Chr20:60885242..61929348 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.33(chr20:60473339-62915555)x3 copy number gain See cases [RCV000446009] Chr20:60473339..62915555 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.2-13.33(chr20:51542616-62915555)x3 copy number gain See cases [RCV000511980] Chr20:51542616..62915555 [GRCh37]
Chr20:20q13.2-13.33		 likely pathogenic
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)x3 copy number gain See cases [RCV000510832] Chr20:61569..62915555 [GRCh37]
Chr20:20p13-q13.33		 pathogenic
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555) copy number gain See cases [RCV000512450] Chr20:61569..62915555 [GRCh37]
Chr20:20p13-q13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:61022397-61738592)x1 copy number loss not provided [RCV000684122] Chr20:61022397..61738592 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20p13-q13.33(chr20:63244-62948788)x3 copy number gain not provided [RCV000741058] Chr20:63244..62948788 [GRCh37]
Chr20:20p13-q13.33		 pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62961294)x3 copy number gain not provided [RCV000741059] Chr20:63244..62961294 [GRCh37]
Chr20:20p13-q13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:60053234-62961294)x3 copy number gain not provided [RCV000741328] Chr20:60053234..62961294 [GRCh37]
Chr20:20q13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:60063645-62961294)x3 copy number gain not provided [RCV000741329] Chr20:60063645..62961294 [GRCh37]
Chr20:20q13.33		 pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62912463)x3 copy number gain not provided [RCV000741057] Chr20:63244..62912463 [GRCh37]
Chr20:20p13-q13.33		 pathogenic
GRCh37/hg19 20q13.2-13.33(chr20:54143747-62194881) copy number gain not provided [RCV000767669] Chr20:54143747..62194881 [GRCh37]
Chr20:20q13.2-13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:61152321-62915555)x1 copy number loss not provided [RCV001007103] Chr20:61152321..62915555 [GRCh37]
Chr20:20q13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:61033338-61412941)x3 copy number gain not provided [RCV000845926] Chr20:61033338..61412941 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.33(chr20:60946209-61975606)x3 copy number gain not provided [RCV000847979] Chr20:60946209..61975606 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.33(chr20:61152321-61282520)x1 copy number loss not provided [RCV001007102] Chr20:61152321..61282520 [GRCh37]
Chr20:20q13.33		 likely benign
NC_000020.10:g.(?_60831241)_(62680869_?)dup duplication Developmental and epileptic encephalopathy, 33 [RCV003107566]|Early infantile epileptic encephalopathy with suppression bursts [RCV003122564] Chr20:60831241..62680869 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.32-13.33(chr20:56788101-62762405)x3 copy number gain not provided [RCV001007098] Chr20:56788101..62762405 [GRCh37]
Chr20:20q13.32-13.33		 pathogenic
GRCh37/hg19 20q13.31-13.33(chr20:55743522-62032989)x3 copy number gain not provided [RCV001007097] Chr20:55743522..62032989 [GRCh37]
Chr20:20q13.31-13.33		 pathogenic
GRCh37/hg19 20q13.2-13.33(chr20:51799648-62916626)x3 copy number gain not provided [RCV001537917] Chr20:51799648..62916626 [GRCh37]
Chr20:20q13.2-13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:61041481-62680992) copy number loss Seizures, benign familial neonatal, 1 [RCV001786555] Chr20:61041481..62680992 [GRCh37]
Chr20:20q13.33		 likely pathogenic
GRCh37/hg19 20q13.33(chr20:61038552-62907579) copy number loss Seizures, benign familial neonatal, 1 [RCV001786557] Chr20:61038552..62907579 [GRCh37]
Chr20:20q13.33		 likely pathogenic
GRCh37/hg19 20q13.32-13.33(chr20:56835739-62915555) copy number gain not specified [RCV002052713] Chr20:56835739..62915555 [GRCh37]
Chr20:20q13.32-13.33		 pathogenic
GRCh37/hg19 20q13.33(chr20:60473339-62915555) copy number gain not specified [RCV002052714] Chr20:60473339..62915555 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.33(chr20:61003263-62915555) copy number loss not specified [RCV002052717] Chr20:61003263..62915555 [GRCh37]
Chr20:20q13.33		 pathogenic
Single allele duplication not specified [RCV002286379] Chr20:61800345..63644611 [GRCh38]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.33(chr20:60621074-62915555)x3 copy number gain not provided [RCV002473575] Chr20:60621074..62915555 [GRCh37]
Chr20:20q13.33		 uncertain significance
GRCh37/hg19 20q13.2-13.33(chr20:52773668-62965020)x3 copy number gain See cases [RCV003329549] Chr20:52773668..62965020 [GRCh37]
Chr20:20q13.2-13.33		 uncertain significance
miRNA Target Status

Confirmed Targets
Gene TargetMature miRNAMethod NameResult TypeData TypeSupport TypePMID
PKMhsa-miR-133aTarbaseexternal_infoOtherPOSITIVE
FSCN1hsa-miR-133aTarbaseexternal_infoReporter GenePOSITIVE
GSTP1hsa-miR-133aTarbaseexternal_infoMicroarrayPOSITIVE
TAGLN2hsa-miR-133aTarbaseexternal_infoqPCRPOSITIVE
TAGLN2hsa-miR-133aTarbaseexternal_infoWesternblitPOSITIVE
RGS3hsa-miR-133aTarbaseexternal_infoReporter GeneNEGATIVE
KCNQ1hsa-miR-133aMirecordsexternal_info{unchanged}NA17443681
CASP9hsa-miR-133aMirecordsexternal_infoNANA17715156
KCNH2hsa-miR-133aMirecordsexternal_info{unchanged}{unchanged}{unchanged}NA17344217
HCN2hsa-miR-133aMirecordsexternal_info{unchanged}NA18458081
PKMhsa-miR-133aMirecordsexternal_infoNANA18464261
KLF15hsa-miR-133aMirecordsexternal_info{unchanged}NA19720047
RHOAhsa-miR-133aMirecordsexternal_infoNANA19644046
KRT7hsa-miR-133aMirecordsexternal_info{changed}NA19378336

Predicted Targets
Summary Value
Count of predictions:39464
Count of gene targets:15996
Count of transcripts:33988
Interacting mature miRNAs:hsa-miR-133a, hsa-miR-133a-5p
Prediction methods:Microtar, Miranda, Pita, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage
High
Medium 2
Low 5 12 2 1 19 17 1 1 3 4 16
Below cutoff 3 32 2 1 2 30 31 4 1 2 1 1 28

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000347538
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2062,564,912 - 62,565,013 (+)Ensembl
RefSeq Acc Id: NR_029676
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382062,564,912 - 62,565,013 (+)NCBI
GRCh372061,162,119 - 61,162,220 (+)RGD
Celera2057,872,455 - 57,872,556 (+)RGD
HuRef2057,916,762 - 57,916,863 (+)ENTREZGENE
CHM1_12061,063,178 - 61,063,279 (+)NCBI
T2T-CHM13v2.02064,363,437 - 64,363,538 (+)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:31518 AgrOrtholog
COSMIC MIR133A2 COSMIC
Ensembl Genes ENSG00000284508 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000347538 ENTREZGENE
GTEx ENSG00000284508 GTEx
HGNC ID HGNC:31518 ENTREZGENE
Human Proteome Map MIR133A2 Human Proteome Map
miRBase MI0000451 ENTREZGENE
NCBI Gene 406923 ENTREZGENE
OMIM 610255 OMIM
PharmGKB PA164722478 PharmGKB
RNAcentral URS0000383E7F RNACentral
  URS00004C9052 RNACentral
  URS000075E14C RNACentral